文献速递青光眼神经眼科

TBK1基因重复致正常眼压性青光眼大家系长期随访

Long-Term Follow-Up of Normal Tension Glaucoma Patients With TBK1 Gene Mutations in One Large Pedigree.
PubMed 文献 · Am J Ophthalmol · 2020-01-24

该回顾性病例系列回顾了一个TBK1基因重复致正常眼压性青光眼家系中7例患者(14眼)的长期资料,初诊平均年龄35±7岁、眼压16±2.1 mmHg,平均随访21.5±9.0年,眼压平均降低28%,67%的患眼视野呈慢至中度进展,43%的患眼最终达到法定盲标准。

要点

  • TBK1相关正常眼压性青光眼患者发病年龄较轻,初诊时已存在严重视神经损害。
  • 长期随访中多数患眼视野呈慢至中度进展,平均MD年变化为-0.53±0.26 dB。
  • 视野变化速率与眼压幅度相关,提示部分患者可能需要设定极低的眼压目标。

核心结论

  • TBK1基因重复相关青光眼具有正常眼压性青光眼的典型特征,患者发病年龄较轻且初诊时病情严重。
  • 多数患眼(67%)视野呈慢至中度进展,视野变化速率似与眼压幅度相关。

研究设计与样本

  • 回顾性观察性病例系列,复习一个TBK1基因重复致正常眼压性青光眼家系中7名成员的病历资料。
  • 共纳入14只研究眼,分析初诊、治疗过程及末次随访时的年龄、眼压、中央角膜厚度、视盘外观和Humphrey视野平均偏差(MD)。

主要发现

  • 初诊时平均年龄35±7岁,眼压16±2.1 mmHg,杯盘比0.9±0.08,14只眼HVF 30-2和/或24-2的MD为-9.0±8.9 dB(范围-1.8至-27 dB)。
  • 初诊时14只眼中4只(28%)无视野缺损,4只(28%)为早期视野缺损,6只(43%)为严重视野缺损。
  • 平均随访21.5±9.0年,眼压平均降低28%;12只眼中4只(33%)视野稳定,8只(67%)呈慢至中度进展。
  • HVF 30-2和/或24-2的MD平均年变化为-0.53±0.26 dB/年,无患眼出现MD年变化>1.0 dB的快速进展。
  • 末次随访时平均眼压11.5±2.9 mmHg,杯盘比0.94±0.4;14只眼中3只(21%)为早期视野缺损,4只(29%)为中度,7只(50%)为严重,6只(43%)达到法定盲标准。

关键数值与推荐

  • 视野缺损按HVF 30-2和/或24-2测试协议评估,初诊时MD为-9.0±8.9 dB(范围-1.8至-27 dB)。
  • 视野进展以MD年变化速率评估,平均为-0.53±0.26 dB/年,快速进展定义为MD年变化>1.0 dB。
  • 法定盲标准:末次随访时14只眼中6只(43%)符合。

临床怎么用

  • 对TBK1相关正常眼压性青光眼患者应长期密切随访视野,关注慢至中度进展。
  • 因视野变化速率似与眼压幅度相关,部分患者可考虑设定极低的眼压目标。

局限性

  • 本研究为单家系回顾性病例系列,样本量小(7名成员、14只眼),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To characterize features of glaucoma associated with a TANK binding kinase 1 (TBK1) gene duplication, which is among the most common molecularly defined causes of normal tension glaucoma (NTG). DESIGN: Retrospective observational case series. METHODS: We conducted a retrospective case series, by reviewing medical records of 7 members of a pedigree with NTG caused by TBK1 gene duplications. Clinical features of these patients at diagnosis, throughout management, and at latest follow-up were identified, including age, intraocular pressure (IOP), central corneal thickness (CCT), optic nerve head appearance, and mean deviation (MD) assessed with Humphrey visual field (HVF) testing protocols. RESULTS: At initial diagnosis, the mean age was 35 ± 7 years, IOP was 16 ± 2.1 mm Hg, cup-to-disc (C/D) ratio was 0.9 ± 0.08, and MD assessed via HVF 30-2 and/or 24-2 testing protocols was -9.0 ± 8.9 (range: -1.8 to -27) dB in the 14 study eyes. At initial diagnosis, 4 of 14 eyes (28%) had no visual field defect, 4 (28%) had early visual field defects, and 6 (43%) had severe visual field defects. Patients had a mean follow-up of 21.5 ± 9.0 years and experienced an average reduction of IOP by 28%. Four of 12 eyes (33%) had stable visual fields throughout follow-up, while 8 eyes (67%) had slow-to-moderate progression. The 30-2 and/or 24-2 HVF tests had an average change in MD of -0.53 ± 0.26 dB/year. No eyes had rapid progression with an MD >1.0 dB/year. At final follow-up, the mean IOP was 11.5 ± 2.9, and C/D ratio was 0.94 ± 0.4. At final follow-up, 3 of 14 eyes (21%) had early visual field defects, 4 (29%) had moderate visual field defects, and 7 (50%) had severe visual field defects. Six of 14 eyes (43%) met criteria for legal blindness. CONCLUSIONS: We provide the first report of the clinical features and long-term clinical course in a family of NTG patients with TBK1 gene duplications. TBK1-associated glaucoma exhibits classic features of NTG. Patients present with severe disease at a relatively early age and most (67%) have slow-to-moderate progression of their visual field defects. The rate of visual field change appears correlated with the magnitude of IOP, suggesting that it may be advantageous to set extremely low IOP targets for some patients with TBK1-associated glaucoma.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Quist TS, Johnson CA, Robin AL, et al. Long-Term Follow-Up of Normal Tension Glaucoma Patients With TBK1 Gene Mutations in One Large Pedigree. Am J Ophthalmol. 2020. PMID: 31987900. doi:10.1016/j.ajo.2020.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。